Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:mesalazine
|
| gptkbp:approvedBy |
1987
|
| gptkbp:ATCCode |
A07EC02
|
| gptkbp:chemicalClass |
aminosalicylate
|
| gptkbp:eliminationHalfLife |
0.7–2.4 hours
|
| gptkbp:excretion |
urine
feces |
| gptkbp:form |
delayed-release tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Asacol
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Allergan
|
| gptkbp:mechanismOfAction |
anti-inflammatory
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
abdominal pain headache |
| gptkbp:usedFor |
gptkb:Crohn's_disease
ulcerative colitis |
| gptkbp:bfsParent |
gptkb:Rhône-Poulenc_Rorer
|
| gptkbp:bfsLayer |
6
|